These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16918471

  • 1. Application of support vector machines to in silico prediction of cytochrome p450 enzyme substrates and inhibitors.
    Yap CW, Xue Y, Li ZR, Chen YZ.
    Curr Top Med Chem; 2006; 6(15):1593-607. PubMed ID: 16918471
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A support vector machine approach to classify human cytochrome P450 3A4 inhibitors.
    Kriegl JM, Arnhold T, Beck B, Fox T.
    J Comput Aided Mol Des; 2005 Mar; 19(3):189-201. PubMed ID: 16059671
    [Abstract] [Full Text] [Related]

  • 7. Structure-activity relationship for human cytochrome P450 substrates and inhibitors.
    Lewis DF, Modi S, Dickins M.
    Drug Metab Rev; 2002 Mar; 34(1-2):69-82. PubMed ID: 11996013
    [Abstract] [Full Text] [Related]

  • 8. In silico modeling of p450 substrates, inhibitors, activators, and inducers.
    DeLisle RK, Otten J, Rhodes S.
    Comb Chem High Throughput Screen; 2011 Jun 01; 14(5):396-416. PubMed ID: 21470185
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
    Crivori P, Poggesi I.
    Eur J Med Chem; 2006 Jul 01; 41(7):795-808. PubMed ID: 16644065
    [Abstract] [Full Text] [Related]

  • 12. Insights into molecular basis of cytochrome p450 inhibitory promiscuity of compounds.
    Cheng F, Yu Y, Zhou Y, Shen Z, Xiao W, Liu G, Li W, Lee PW, Tang Y.
    J Chem Inf Model; 2011 Oct 24; 51(10):2482-95. PubMed ID: 21875141
    [Abstract] [Full Text] [Related]

  • 13. Prediction of drug metabolism: the case of cytochrome P450 2D6.
    Vermeulen NP.
    Curr Top Med Chem; 2003 Oct 24; 3(11):1227-39. PubMed ID: 12769702
    [Abstract] [Full Text] [Related]

  • 14. Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design.
    Rekka EA, Kourounakis PN, Pantelidou M.
    Curr Top Med Chem; 2019 Oct 24; 19(4):276-291. PubMed ID: 30706817
    [Abstract] [Full Text] [Related]

  • 15. Electrochemical investigations of cytochrome P450.
    Shumyantseva VV, Bulko TV, Suprun EV, Chalenko YM, Vagin MY, Rudakov YO, Shatskaya MA, Archakov AI.
    Biochim Biophys Acta; 2011 Jan 24; 1814(1):94-101. PubMed ID: 20650335
    [Abstract] [Full Text] [Related]

  • 16. Prediction of human cytochrome P450 2B6-substrate interactions using hierarchical support vector regression approach.
    Leong MK, Chen YM, Chen TH.
    J Comput Chem; 2009 Sep 24; 30(12):1899-909. PubMed ID: 19115281
    [Abstract] [Full Text] [Related]

  • 17. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K, Von Moltke LL, Greenblatt DJ.
    J Clin Pharmacol; 2001 Nov 24; 41(11):1149-79. PubMed ID: 11697750
    [Abstract] [Full Text] [Related]

  • 18. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.
    Tyzack JD, Kirchmair J.
    Chem Biol Drug Des; 2019 Apr 24; 93(4):377-386. PubMed ID: 30471192
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors.
    Kontijevskis A, Komorowski J, Wikberg JE.
    J Chem Inf Model; 2008 Sep 24; 48(9):1840-50. PubMed ID: 18693719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.